
Our NASH animal models undergo rigorous quality assessments to guarantee reliability in research outcomes, aligning with GLP standards for reproducibility and scientific integrity.
With experienced professionals, KCI Biotech delivers unmatched expertise in preclinical research, ensuring the NASH animal models are precise and reliable for various drug development applications.
We accommodate varying project sizes with flexible minimum order quantities, allowing our clients to scale research efforts efficiently without compromising on quality.
KCI Biotech prioritizes timely delivery of NASH animal models, facilitating swift project initiation and adherence to research timelines, which is crucial in the fast-paced pharmaceutical realm.





Comprehensive preclinical drug development and service platform
Building A2, No, 8 Yanghua road, Suzhou industrial Park, Suzhou.P.R, china